APA (7th ed.) Citation

T, M., MJ, Z., K, Y., J, M., K, T., H, H., . . . H, K. (2022). Effect of Cyclosporin A and Impact of Dose Staggering on OATP1B1/1B3 Endogenous Substrates and Drug Probes for Assessing Clinical Drug Interactions. Clinical pharmacology and therapeutics, 111(6), 1315. https://doi.org/10.1002/cpt.2584

Chicago Style (17th ed.) Citation

T, Mochizuki, et al. "Effect of Cyclosporin A and Impact of Dose Staggering on OATP1B1/1B3 Endogenous Substrates and Drug Probes for Assessing Clinical Drug Interactions." Clinical Pharmacology and Therapeutics 111, no. 6 (2022): 1315. https://doi.org/10.1002/cpt.2584.

MLA (9th ed.) Citation

T, Mochizuki, et al. "Effect of Cyclosporin A and Impact of Dose Staggering on OATP1B1/1B3 Endogenous Substrates and Drug Probes for Assessing Clinical Drug Interactions." Clinical Pharmacology and Therapeutics, vol. 111, no. 6, 2022, p. 1315, https://doi.org/10.1002/cpt.2584.